<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04954222</url>
  </required_header>
  <id_info>
    <org_study_id>21-001028</org_study_id>
    <nct_id>NCT04954222</nct_id>
  </id_info>
  <brief_title>Recovery of Respiratory System in COVID-19 Patients</brief_title>
  <official_title>Tracking the Recovery of Respiratory Physiology in COVID-19 Patients a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of the clinical course of treatment as&#xD;
      well as long-term symptoms of COVID-19 on respiratory function, exercise capacity, and&#xD;
      quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in diffusion capacity of the lungs</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>change in diffusing capacity of the lungs for carbon monoxide and its components</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in airway morphology</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>CT assessment of airway diameter and thickness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change basic spirometry</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>Measurement of basic lung function using forced vital capacity (FVC), slow vital capacity (SVC),&#xD;
forced expiratory volume at one second (FEV1), maximal inspiratory pressure (MIPS), maximal expiratory pressure (MEPS), exhaled nitric oxide (ExNO), forced oscillation technique (FOT), overnight pulse oximetry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in peak aerobic capacity</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>Change in examine post exertional malaise</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of post-exertional malaise</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>Evaluation of change in performance on maximal exercise test over two days to identify presence of post-exertional malaise</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in symptoms</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>St. George's respiratory Questionnaire scoring of pulmonary symptoms. Scores range from 0 to 100, with higher scores indicating more limitations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in quality of life</measure>
    <time_frame>through study completion, an average of 5 months</time_frame>
    <description>SF-36 questionnaire assessment of physical and mental health. Two scores one for physical functioning and one for mental functioning. Scores range from 0-100 with a higher score indicating better health</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>COVID19 long haulers</arm_group_label>
    <description>Individuals that have been diagnosed with COVID19 and continue to have lingering symptoms associated with COVID19</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID19 no residual symptoms</arm_group_label>
    <description>Individuals that have been diagnosed with COVID19 and do not have lingering symptoms that are associated with COVID19</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female participants that have tested positive for COVID-19 within 28 or more days&#xD;
        will be recruited for this study. Individuals with or without continuing symptoms of&#xD;
        COVID-19 can participate.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have a documented positive qRT-PCR for SARS-CoV-2 confirming prior COVID-19 diagnosis&#xD;
             within the last 28 days&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
          -  Female subjects must not be pregnant or trying to become pregnant during the duration&#xD;
             of study participation.&#xD;
&#xD;
          -  No known plans to move out of the state, or become unable to return to one of the Mayo&#xD;
             Clinic sites for follow-up testing.&#xD;
&#xD;
          -  Must be able to provide clear informed written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals with pacemakers or other implantable devices that will make interpreting a&#xD;
             CT scan challenging.&#xD;
&#xD;
          -  Individuals with major limitations to exercise.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce D Johnson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Courtney M. Wheatley</investigator_full_name>
    <investigator_title>Co-Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

